Slideshow
Author(s):
To kick off Migraine and Headache Awareness Month, the latest findings reported here may influence your approaches to diagnosis, treatment, and prevention and help you keep your patients informed.
FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment